FDLI: Enforcement, Litigation, & Compliance Conference 2026

ProPharma will be attending the FDLI Enforcement, Litigation, and Compliance Conference 2026, taking place December 10–11, 2026, in Washington, D.C. The conference brings together leaders from industry, government, and private practice to examine the latest developments in FDA enforcement, compliance, litigation, and risk management across the drug, device, food, and tobacco sectors.

As enforcement priorities and regulatory expectations continue to evolve, organizations are challenged to proactively manage risk while maintaining compliance across every stage of the product lifecycle. ProPharma works with life sciences companies to develop practical, forward-looking strategies that strengthen regulatory readiness, support quality systems, and help organizations confidently navigate an increasingly complex environment.

Throughout the conference, our team will be engaging with industry leaders to discuss emerging enforcement trends, compliance strategies, and the evolving regulatory landscape impacting FDA-regulated products.

Connect with ProPharma at the FDLI Enforcement, Litigation, and Compliance Conference 2026 to learn how our regulatory, quality, and compliance expertise can help your organization stay ahead of today's evolving challenges.